Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New anesthesia combo may improve safety during lung procedures

NCT ID NCT07409935

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether adding dexmedetomidine to propofol during rigid bronchoscopy (a procedure to examine the airways) leads to more stable heart rates and fewer complications. Fifty adults were randomly assigned to receive either propofol alone or propofol plus dexmedetomidine. The goal was to see if the combination could improve safety and recovery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
propofol and dexmedetomidine
What this could lead to
If successful, this could lead to a more stable and safer anesthesia method for rigid bronchoscopy procedures.
What could go wrong
This is a small, completed Phase 4 trial with only 50 participants, so results may not apply to all patients. The study focuses on short-term outcomes, not long-term benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

50 people

The number who actually took part.

Started

Apr 2024

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged 18 - 60 years, scheduled for elective rigid bronchoscopy procedure. * ASA physical status I-II * Both genders. Exclusion Criteria: * Patient refusal. * Known allergy to any of the used drugs. * Bleeding disorders. * Hemodynamically unstable patients ( mean arterial blood pressure \[MAP\] \< 60 mmHg). * Tracheostomy tube in situ. * Patients with stridor and any upper airway emergency.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Patients undergoing rigid bronchoscopy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cairo University

    Cairo, Cairo Governorate, Egypt